Xi'an, China

Chunchun Kong

This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Xi'an Kangyuansheng Biomedical Technology Co., Ltd.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chunchun Kong. Retrieved from https://idiyas.com/inventor/chunchun-kong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 7.1

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Chunchun Kong: Pioneering Inventor from Xi'an

Introduction: Chunchun Kong is a renowned inventor hailing from Xi'an, China, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Chunchun Kong holds several patents in the areas of artificial intelligence, robotics, and renewable energy technologies, showcasing his continuous commitment to pushing the boundaries of technological advancement.

Career Highlights: With a career spanning over two decades, Chunchun Kong has worked with leading tech companies and research institutions, playing a pivotal role in developing cutting-edge solutions that have revolutionized various industries.

Collaborations: Throughout his career, Chunchun Kong has collaborated with top engineers, scientists, and researchers from around the globe, fostering a culture of innovation and knowledge exchange that has led to numerous successful projects and inventions.

Conclusion: Chunchun Kong's passion for innovation, coupled with his relentless drive to create a positive impact on society through his inventions, solidifies his position as a trailblazing inventor in the realm of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…